 | • レポートコード：QYR2104Z1386 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、クローン化コンピテントセルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（20*100μl、50*100μl、100*100μl、その他）、用途別市場規模（サブクローニング・ルーチンクローニング、ファージディスプレイライブラリー構築、有毒/不安定Dnaクローニング、ハイスループットクローニング）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クローン化コンピテントセルの市場動向 ・企業の競争状況、市場シェア ・クローン化コンピテントセルの種類別市場規模（20*100μl、50*100μl、100*100μl、その他） ・クローン化コンピテントセルの用途別市場規模（サブクローニング・ルーチンクローニング、ファージディスプレイライブラリー構築、有毒/不安定Dnaクローニング、ハイスループットクローニング） ・クローン化コンピテントセルの北米市場規模2016-2027（アメリカ、カナダ） ・クローン化コンピテントセルのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クローン化コンピテントセルのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クローン化コンピテントセルの中南米市場規模2016-2027（メキシコ、ブラジル） ・クローン化コンピテントセルの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck KGaA、Thermo Fisher Scientific、Agilent Technologies、Takara Bio、Promega Corporation、Beijing TransGen Biotech、GeneScript Corporation、Yeastern Biotech、New England Biolabs、QIAGEN N.V.、OriGene Technologies、Lucigen、Zymo Research、Bio-Rad Laboratories、Bioline） ・結論 |
Competent cells, designed to take up foreign DNA from the surrounding at a higher efficiency, are routinely used in molecular cloning to propagate and maintain cloned DNA in plasmids.
Market Analysis and Insights: Global Cloned Competent Cells Market
The global Cloned Competent Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cloned Competent Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cloned Competent Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cloned Competent Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cloned Competent Cells market.
Global Cloned Competent Cells Scope and Market Size
Cloned Competent Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cloned Competent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
20*100μl
50*100μl
100*100μl
Other
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
Takara Bio
Promega Corporation
Lucigen
Zymo Research
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cloned Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 20*100μl
1.2.3 50*100μl
1.2.4 100*100μl
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cloned Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable Dna Cloning
1.3.5 High-Throughput Cloning
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cloned Competent Cells Market Perspective (2016-2027)
2.2 Cloned Competent Cells Growth Trends by Regions
2.2.1 Cloned Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cloned Competent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Cloned Competent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Cloned Competent Cells Industry Dynamic
2.3.1 Cloned Competent Cells Market Trends
2.3.2 Cloned Competent Cells Market Drivers
2.3.3 Cloned Competent Cells Market Challenges
2.3.4 Cloned Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cloned Competent Cells Players by Revenue
3.1.1 Global Top Cloned Competent Cells Players by Revenue (2016-2021)
3.1.2 Global Cloned Competent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Cloned Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cloned Competent Cells Revenue
3.4 Global Cloned Competent Cells Market Concentration Ratio
3.4.1 Global Cloned Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cloned Competent Cells Revenue in 2020
3.5 Cloned Competent Cells Key Players Head office and Area Served
3.6 Key Players Cloned Competent Cells Product Solution and Service
3.7 Date of Enter into Cloned Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cloned Competent Cells Breakdown Data by Type
4.1 Global Cloned Competent Cells Historic Market Size by Type (2016-2021)
4.2 Global Cloned Competent Cells Forecasted Market Size by Type (2022-2027)
5 Cloned Competent Cells Breakdown Data by Application
5.1 Global Cloned Competent Cells Historic Market Size by Application (2016-2021)
5.2 Global Cloned Competent Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cloned Competent Cells Market Size (2016-2027)
6.2 North America Cloned Competent Cells Market Size by Type
6.2.1 North America Cloned Competent Cells Market Size by Type (2016-2021)
6.2.2 North America Cloned Competent Cells Market Size by Type (2022-2027)
6.2.3 North America Cloned Competent Cells Market Size by Type (2016-2027)
6.3 North America Cloned Competent Cells Market Size by Application
6.3.1 North America Cloned Competent Cells Market Size by Application (2016-2021)
6.3.2 North America Cloned Competent Cells Market Size by Application (2022-2027)
6.3.3 North America Cloned Competent Cells Market Size by Application (2016-2027)
6.4 North America Cloned Competent Cells Market Size by Country
6.4.1 North America Cloned Competent Cells Market Size by Country (2016-2021)
6.4.2 North America Cloned Competent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cloned Competent Cells Market Size (2016-2027)
7.2 Europe Cloned Competent Cells Market Size by Type
7.2.1 Europe Cloned Competent Cells Market Size by Type (2016-2021)
7.2.2 Europe Cloned Competent Cells Market Size by Type (2022-2027)
7.2.3 Europe Cloned Competent Cells Market Size by Type (2016-2027)
7.3 Europe Cloned Competent Cells Market Size by Application
7.3.1 Europe Cloned Competent Cells Market Size by Application (2016-2021)
7.3.2 Europe Cloned Competent Cells Market Size by Application (2022-2027)
7.3.3 Europe Cloned Competent Cells Market Size by Application (2016-2027)
7.4 Europe Cloned Competent Cells Market Size by Country
7.4.1 Europe Cloned Competent Cells Market Size by Country (2016-2021)
7.4.2 Europe Cloned Competent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cloned Competent Cells Market Size (2016-2027)
8.2 Asia-Pacific Cloned Competent Cells Market Size by Type
8.2.1 Asia-Pacific Cloned Competent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cloned Competent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cloned Competent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Cloned Competent Cells Market Size by Application
8.3.1 Asia-Pacific Cloned Competent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cloned Competent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cloned Competent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Cloned Competent Cells Market Size by Region
8.4.1 Asia-Pacific Cloned Competent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cloned Competent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cloned Competent Cells Market Size (2016-2027)
9.2 Latin America Cloned Competent Cells Market Size by Type
9.2.1 Latin America Cloned Competent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Cloned Competent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Cloned Competent Cells Market Size by Type (2016-2027)
9.3 Latin America Cloned Competent Cells Market Size by Application
9.3.1 Latin America Cloned Competent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Cloned Competent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Cloned Competent Cells Market Size by Application (2016-2027)
9.4 Latin America Cloned Competent Cells Market Size by Country
9.4.1 Latin America Cloned Competent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Cloned Competent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cloned Competent Cells Market Size (2016-2027)
10.2 Middle East & Africa Cloned Competent Cells Market Size by Type
10.2.1 Middle East & Africa Cloned Competent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cloned Competent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cloned Competent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Cloned Competent Cells Market Size by Application
10.3.1 Middle East & Africa Cloned Competent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cloned Competent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cloned Competent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Cloned Competent Cells Market Size by Country
10.4.1 Middle East & Africa Cloned Competent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cloned Competent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Cloned Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Cloned Competent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Cloned Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Cloned Competent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Cloned Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Cloned Competent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Cloned Competent Cells Introduction
11.4.4 Takara Bio Revenue in Cloned Competent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Cloned Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Cloned Competent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Cloned Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Cloned Competent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Cloned Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Cloned Competent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Cloned Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Cloned Competent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Cloned Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Cloned Competent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Cloned Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Cloned Competent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Cloned Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Cloned Competent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Cloned Competent Cells Introduction
11.12.4 Lucigen Revenue in Cloned Competent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Cloned Competent Cells Introduction
11.13.4 Zymo Research Revenue in Cloned Competent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Cloned Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Cloned Competent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Cloned Competent Cells Introduction
11.15.4 Bioline Revenue in Cloned Competent Cells Business (2016-2021)
11.15.5 Bioline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cloned Competent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 20*100μl
Table 3. Key Players of 50*100μl
Table 4. Key Players of 100*100μl
Table 5. Key Players of Other
Table 6. Global Cloned Competent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cloned Competent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cloned Competent Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cloned Competent Cells Market Share by Regions (2016-2021)
Table 10. Global Cloned Competent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cloned Competent Cells Market Share by Regions (2022-2027)
Table 12. Cloned Competent Cells Market Trends
Table 13. Cloned Competent Cells Market Drivers
Table 14. Cloned Competent Cells Market Challenges
Table 15. Cloned Competent Cells Market Restraints
Table 16. Global Cloned Competent Cells Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cloned Competent Cells Market Share by Players (2016-2021)
Table 18. Global Top Cloned Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cloned Competent Cells as of 2020)
Table 19. Ranking of Global Top Cloned Competent Cells Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cloned Competent Cells Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cloned Competent Cells Product Solution and Service
Table 23. Date of Enter into Cloned Competent Cells Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cloned Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cloned Competent Cells Revenue Market Share by Type (2016-2021)
Table 27. Global Cloned Competent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cloned Competent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cloned Competent Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cloned Competent Cells Revenue Market Share by Application (2016-2021)
Table 31. Global Cloned Competent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cloned Competent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cloned Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cloned Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cloned Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cloned Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cloned Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cloned Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cloned Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cloned Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cloned Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cloned Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cloned Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cloned Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cloned Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cloned Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cloned Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cloned Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cloned Competent Cells Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cloned Competent Cells Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cloned Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cloned Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cloned Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cloned Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cloned Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cloned Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cloned Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cloned Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cloned Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cloned Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cloned Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cloned Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Cloned Competent Cells Product
Table 66. Merck KGaA Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Cloned Competent Cells Product
Table 71. Thermo Fisher Scientific Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Cloned Competent Cells Product
Table 76. Agilent Technologies Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 77. Agilent Technologies Recent Development
Table 78. Takara Bio Company Details
Table 79. Takara Bio Business Overview
Table 80. Takara Bio Cloned Competent Cells Product
Table 81. Takara Bio Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 82. Takara Bio Recent Development
Table 83. Promega Corporation Company Details
Table 84. Promega Corporation Business Overview
Table 85. Promega Corporation Cloned Competent Cells Product
Table 86. Promega Corporation Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 87. Promega Corporation Recent Development
Table 88. Beijing TransGen Biotech Company Details
Table 89. Beijing TransGen Biotech Business Overview
Table 90. Beijing TransGen Biotech Cloned Competent Cells Product
Table 91. Beijing TransGen Biotech Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 92. Beijing TransGen Biotech Recent Development
Table 93. GeneScript Corporation Company Details
Table 94. GeneScript Corporation Business Overview
Table 95. GeneScript Corporation Cloned Competent Cells Product
Table 96. GeneScript Corporation Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 97. GeneScript Corporation Recent Development
Table 98. Yeastern Biotech Company Details
Table 99. Yeastern Biotech Business Overview
Table 100. Yeastern Biotech Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 101. Yeastern Biotech Recent Development
Table 102. New England Biolabs Company Details
Table 103. New England Biolabs Business Overview
Table 104. New England Biolabs Cloned Competent Cells Product
Table 105. New England Biolabs Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 106. New England Biolabs Recent Development
Table 107. QIAGEN N.V. Company Details
Table 108. QIAGEN N.V. Business Overview
Table 109. QIAGEN N.V. Cloned Competent Cells Product
Table 110. QIAGEN N.V. Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 111. QIAGEN N.V. Recent Development
Table 112. OriGene Technologies Company Details
Table 113. OriGene Technologies Business Overview
Table 114. OriGene Technologies Cloned Competent Cells Product
Table 115. OriGene Technologies Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 116. OriGene Technologies Recent Development
Table 117. Lucigen Company Details
Table 118. Lucigen Business Overview
Table 119. Lucigen Cloned Competent Cells Product
Table 120. Lucigen Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 121. Lucigen Recent Development
Table 122. Zymo Research Company Details
Table 123. Zymo Research Business Overview
Table 124. Zymo Research Cloned Competent Cells Product
Table 125. Zymo Research Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 126. Zymo Research Recent Development
Table 127. Bio-Rad Laboratories Company Details
Table 128. Bio-Rad Laboratories Business Overview
Table 129. Bio-Rad Laboratories Cloned Competent Cells Product
Table 130. Bio-Rad Laboratories Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 131. Bio-Rad Laboratories Recent Development
Table 132. Bioline Company Details
Table 133. Bioline Business Overview
Table 134. Bioline Cloned Competent Cells Product
Table 135. Bioline Revenue in Cloned Competent Cells Business (2016-2021) & (US$ Million)
Table 136. Bioline Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cloned Competent Cells Market Share by Type: 2020 VS 2027
Figure 2. 20*100μl Features
Figure 3. 50*100μl Features
Figure 4. 100*100μl Features
Figure 5. Other Features
Figure 6. Global Cloned Competent Cells Market Share by Application: 2020 VS 2027
Figure 7. Subcloning & Routine Cloning Case Studies
Figure 8. Phage Display Library Construction Case Studies
Figure 9. Toxic/Unstable Dna Cloning Case Studies
Figure 10. High-Throughput Cloning Case Studies
Figure 11. Cloned Competent Cells Report Years Considered
Figure 12. Global Cloned Competent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cloned Competent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cloned Competent Cells Market Share by Regions: 2020 VS 2027
Figure 15. Global Cloned Competent Cells Market Share by Regions (2022-2027)
Figure 16. Global Cloned Competent Cells Market Share by Players in 2020
Figure 17. Global Top Cloned Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cloned Competent Cells as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cloned Competent Cells Revenue in 2020
Figure 19. Global Cloned Competent Cells Revenue Market Share by Type (2016-2021)
Figure 20. Global Cloned Competent Cells Revenue Market Share by Type (2022-2027)
Figure 21. North America Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cloned Competent Cells Market Share by Type (2016-2027)
Figure 23. North America Cloned Competent Cells Market Share by Application (2016-2027)
Figure 24. North America Cloned Competent Cells Market Share by Country (2016-2027)
Figure 25. United States Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cloned Competent Cells Market Share by Type (2016-2027)
Figure 29. Europe Cloned Competent Cells Market Share by Application (2016-2027)
Figure 30. Europe Cloned Competent Cells Market Share by Country (2016-2027)
Figure 31. Germany Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cloned Competent Cells Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cloned Competent Cells Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cloned Competent Cells Market Share by Region (2016-2027)
Figure 41. China Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cloned Competent Cells Market Share by Type (2016-2027)
Figure 49. Latin America Cloned Competent Cells Market Share by Application (2016-2027)
Figure 50. Latin America Cloned Competent Cells Market Share by Country (2016-2027)
Figure 51. Mexico Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cloned Competent Cells Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cloned Competent Cells Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cloned Competent Cells Market Share by Country (2016-2027)
Figure 57. Turkey Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cloned Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Merck KGaA Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 62. Agilent Technologies Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 63. Takara Bio Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 64. Promega Corporation Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 65. Beijing TransGen Biotech Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 66. GeneScript Corporation Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 67. Yeastern Biotech Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 68. New England Biolabs Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 69. QIAGEN N.V. Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 70. OriGene Technologies Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 71. Lucigen Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 72. Zymo Research Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 73. Bio-Rad Laboratories Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 74. Bioline Revenue Growth Rate in Cloned Competent Cells Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の化学的コンピテントセル市場規模・現状・予測（2021年-2027年） Chemically competent cells are calcium chloride treated to facilitate attachment of the plasmid DNA to the competent cell membrane. Chemically competent cells are the best solution for general cloning and subcloning application Market Analysis and Insights: Global Chemically Competent Cells Market T…- 世界のコンピテントセル市場規模・現状・予測（2021年-2027年） Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for a…
- 世界の発現用コンピテントセル市場規模・現状・予測（2021年-2027年） Expressed Competent cells are bacterial cells that can accept extra-chromosomal DNA or plasmids (naked DNA) from the environment. ... Bacteria can also be made competent artificially by chemical treatment and heat shock to make them transiently permeable to DNA. Market Analysis and Insights: Global …
- 世界のエレクトロコンピテントセル市場規模・現状・予測（2021年-2027年） Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency. Market Analysis and Insights:…
- 世界のクローン用コンピテントセル市場規模・現状・予測（2021年-2027年） Competent cells, designed to take up foreign DNA from the surrounding at a higher efficiency, are routinely used in molecular cloning to propagate and maintain cloned DNA in plasmids Market Analysis and Insights: Global Clone Competent Cell Market The global Clone Competent Cell market size is proje…